Cytokine therapies have the potential to transform cancer treatment by enhancing the body’s immune response to fight cancer ...
The FDA has approved Caris Life Sciences’ MI Cancer Seek, a pioneering diagnostic test combining Whole Exome and Whole ...
New data from the Phase 2 OVATION 2 study highlights potential improvements in survival outcomes with IMUNON's IMNN-001 for ...
Comprehensive Genomic Profiling (CGP) is reshaping cancer treatment by enabling precision oncology at an unprecedented scale.
Antibody-drug conjugates (ADCs) represent a significant breakthrough in oncology, offering targeted treatments, especially for lung cancer. In this insightful interview with Dr. Nicolas Girard, Head ...
Don't miss this opportunity to hear their insights and get answers to your questions on how AI is shaping the future of healthcare. The general overview of your report, "AI In Pharmaceuticals Promises ...
This novel DNA plasmid vaccine targets antigen-presenting cells and aims to induce a robust immune response. Prof. Lindy Durrant, CEO of Scancell, shared insights from the latest Phase 2 SCOPE trial ...
The U.S. Food and Drug Administration (FDA) has approved Thermo Fisher’s Oncomine Dx Target Test, a next-generation sequencing (NGS)-based companion diagnostic, to identify patients eligible for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback